ArticleJournal of family medicine and primary care2022
Seroprevalence of CoVID-19 among health care professionals (HCPs) of tertiary care hospital of northern state of India.
Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A longitudinal study depicting persistence of COVID-19 antibodies after half a year using chemiluminescent microparticle immunoassay among healthcare workers and frontline workers in Mumbai, India's largest metropoli.Journal of family medicine and primary care · 2025Article
- Impact of COVID-19 Vaccination on Seroprevalence of SARS-CoV-2 among the Health Care Workers in a Tertiary Care Centre, South India.Vaccines · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Current study was carried out as per the government of India and Himachal Pradesh guidelines to carry out a serosurvey to assess the extent of COVID-19 infection among health care professionals (HCPs) after 6 months of managing COVID-19 cases. Methods: A hospital-based survey was carried out among 1279 conveniently selected HCPs from September 2020 to January 2021. Results: The participants had a mean age of 38.3 (±10.4) years, and almost half (47.4%) were ≤35 years of age. A total of 29 (2.3%) were already tested positive for COVID-19 (RT-PCR: 22; Rapid Antigen Test: 7) before the survey, and the overall prevalence of IgG antibody was 12.7% among the participants (Male: 12.8%; Females: 12.5%). The odds were observed significantly high among administrative staff (aOR: 5.09; 95%CI: 1.27-20.33) and participants tested positive of COVID-19 previously (aOR: 28.41; 95%CI: 11.71-69.00). Conclusion: HCPs were tested about 6 months after the initiation of the COVID-19 pandemic in the state and demonstrated a high and expected level of seroprevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.